Advanced search
Publication Cover
Cancer Investigation Volume 20, 2002 - Issue 1
Submit an article Journal homepage
30
Views
1
CrossRef citations to date
0
Altmetric
Original

Experience with Methotrexate, 5-Fluorouracil, and Leucovorin (MFL): A First Line Effective, Minimally Toxic Regimen for Metastatic Breast Cancer

Michael Auerbach Divisions of Medical and Surgical Oncology, Franklin Square Hospital Center, Baltimore, Maryland, 21237, U.S.A.
, M.D.,
E. George Elias Divisions of Medical and Surgical Oncology, Franklin Square Hospital Center, Baltimore, Maryland, 21237, U.S.A.
, M.D. &
James Orford Divisions of Medical and Surgical Oncology, Franklin Square Hospital Center, Baltimore, Maryland, 21237, U.S.A.
, M.D.
Pages 24-28 | Published online: 22 Apr 2002

REFERENCES

  • Landis S.H., Murray T., Bolden S., , et al. Cancer Statist. 1998; 48: 6–29
  • Seidman H., Mushinski M.H., Gelb S.K., , et al. Probability of Eventually Developing or Dying of Cancer—United States CA. A Cancer J. for Clinicians 1985; 35: 36–56
  • Harris J., Morrow M., Norton L. Malignant Tumors of the Breast. Cancer Principles and Practice of Oncology, V. Devita, S. Hellman, S.A. Rosenberg. Lippincott-Raven, Philadelphia, PA 1997; 1557–1616
  • Bertino J.R., Sawicki W.L., Lindquist C.A., , et al. Schedule Dependent Antitumor Effects of Methotrexate and 5-Fluorouracil. Cancer Res. 1977; 37: 327–337
  • Cadman E., Heimer R., Davis L. Enhanced 5-Fluorouracil Nucleotide Formation after Methotrexate Administration Explanation for Drug Synergism. Science 1979; 205: 1136–1146
  • Fisher B., Dignam J., Mamounas P., , et al. Sequential Methotrexate and Fluorouracil for the Treatment of Node Negative Breast Cancer Patients with Estrogen Receptor Negative Tumors: Eight Year Results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B13 and First Report of Findings from NSABP B-19 Comparing Methotrexate and Fluorouracil with Conventional Cyclophosphamide, Methotrexate and Fluorouracil. JCO 1996; 14: 1982–1992
  • Fisher B., Redmond C., Dimitrov N.V., , et al. A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node Negative Breast Cancer Who have Estrogen Receptor Negative Tumors. NEJM 1989; 320: 473–478
  • Muss H., Case L., Richards F., , et al. Interrupted vs. Continuous Chemotherapy in Patients with Metastatic Breast Cancer. NEJM 1991; 325: 1342–1346
  • Chan S., Friedrichs K., Noel D., , et al. Prospective Randomized Trial of Docetaxel vs. Doxorubicin in Patients with Metastatic Breast Cancer. The 303 Study Group. JCO 1999; 8: 2341–2354
  • Hortobagyi G.N. Paclitaxel-based Combination Chemotherapy for Breast Cancer. Oncology (Huntingt) 1997; 3(Suppl. 2)29–37
  • Conte P.F., Baldini E., Michelotti A., , et al. Paclitaxel Combinations as Front-Line and Salvage Chemotherapy Regimens in Advanced Breast Cancer. Semin. Oncol. 1996; 6(Suppl. 15)39–42

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.